Cytek Biosciences, Inc.
CTKB· Nasdaq
Released Nov 7, 2023, after the close
10-Q filed Nov 14, 2023, 45 days after period end · 0001628280-23-038974
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $48.00M | $40.48M | $34.38M | $25.10M |
| Net Income | -$6.46M | $1.63M | $1.42M | $6.54M |
| EPS Diluted |
Cytek Biosciences, Inc. · CIK 1831915 · Engraved from SEC EDGAR
| -$0.05 |
| -$0.01 |
| $0.00 |
| $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.